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Introduction {#sec1}
============

The use of human pluripotent stem cells (hPSCs) in studying human biology and disease requires precise genome-targeting methodologies. While different from mouse cells, gene targeting in either human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) is found to be technically difficult ([@bib4], [@bib25], [@bib56]). This situation is now much improved with the development of the custom-engineered nucleases (CENs) ([@bib22]). CENs are designed to introduce site-specific double-strand breaks (DSBs) within the genome, which trigger DNA repair and therefore facilitate genetic engineering ([@bib22], [@bib29]). To date three CENs have been developed, among which the type II clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system is increasingly preferred, based on its high efficiency and less laboriousness compared with zinc-finger nucleases and transcription activator-like effector nucleases ([@bib14], [@bib27]).

The type II CRISPR/Cas9 system relies on three components as follows: the DNA nuclease Cas9, the CRISPR RNA (crRNA), and *trans*-activating crRNA (tracrRNA) ([@bib34]). To facilitate laboratory use, a single guide RNA (gRNA), which is encoded by a single vector plasmid ([@bib10], [@bib11], [@bib42]), has now replaced the crRNA/tracrRNA duplex. The gRNA contains a 15- to 23-bp target DNA-matching sequence immediately upstream of a protospacer adjacent motif (PAM) ([@bib16], [@bib28], [@bib48]). The CRISPR/Cas9 derived from *Streptococcus pyogenes* is the most widely used system and has a 5′-NGG-3′ PAM ([@bib11], [@bib42]). The 15- to 23-bp-long complementary sequence binds to the target genomic locus through strict Watson-Crick pairing ([@bib16], [@bib28], [@bib48]), where the gRNA directs Cas9 for DNA cleavage and therefore results in a DSB at a desired site ([@bib34]). A DSB introduced into the genome will initiate DNA repair through either error-prone non-homologous end joining (NHEJ) or homology-directed repair (HDR) in the presence of exogenous DNA templates ([@bib17], [@bib23], [@bib32], [@bib37]).

Both NHEJ and HDR have been used in hPSCs for gene editing ([@bib2], [@bib6], [@bib13], [@bib14], [@bib18], [@bib26], [@bib27], [@bib36], [@bib46]). For targeted gene knockout in hPSCs, NHEJ usually causes unpredicted insertions/deletions (indels), which makes the validation process technically troublesome and always generates unpredictable non-naturally existent proteins because of the frameshift introduced ([@bib8], [@bib20]). In addition, NHEJ cannot be applied for efficient knockout of non-coding RNAs. For HDR-mediated gene knockout in hPSCs, a recombination donor, which consists of the 5′ homology arm, an exon-replacing module and/or drug-resistant selection module, and the 3′ homology arm, is required for proper homologous recombination. Although outcome is predictable, the targeting efficiency of the HDR-based system is low and variable ([@bib19], [@bib25], [@bib41], [@bib56]). Moreover, the requirement for construction of the multimodule donor vector renders this system time consuming and labor intensive.

Here, we report an efficient paired gRNA-guided CRISPR/Cas9 knockout (paired-KO) method in hPSCs. Introducing a pair of gRNAs and Cas9 into hPSCs caused two DSBs, which were subsequently repaired with precise ligation without indels. Since each gRNA/Cas9 cleaves the targeting sequences between positions −3 and −4 upstream of the PAM sequence in a predictable manner, this paired gRNA strategy can serve as a powerful tool for coding gene knockout as long as the DSBs are designed shortly downstream of the ATG start codon and the frameshift triggers an immediate premature translation termination codon (PTC) downward. The paired-KO method also worked well for multiplexable gene targeting, and was equivalently efficient for lesion of microRNA (miRNA) and long non-coding RNA (lncRNA). We therefore conclude that the current paired-KO strategy is a rapid, robust, outcome-predictable, and multiplexable genome-editing methodology, which benefits loss-of-function studies of both coding and non-coding genes in hPSCs.

Results {#sec2}
=======

Paired-KO Represents a Robust and Predictable Strategy for Gene Knockout in hPSCs {#sec2.1}
---------------------------------------------------------------------------------

CRISPR/Cas9-introduced DSB mostly initiates NHEJ for DNA repair in the absence of recombination donors and is thus applied for gene lesion or mutation in cultured cells and animal models ([@bib8], [@bib11], [@bib20], [@bib45], [@bib49]). It has been reported that introducing two DSBs could potentially increase the gene-targeting efficiency or induce genomic DNA-fragment deletion ([@bib3], [@bib35], [@bib43], [@bib53], [@bib54]). To ablate *SMAD3* in hESCs, we designed two adjacent gRNAs in exon 3 of *SMAD3* genome immediately downstream of the ATG start codon ([Figure 1](#fig1){ref-type="fig"}A). Both gRNAs and CAG promoter-driven Cas9-P2A-GFP vector were then co-electroporated into H9 hESCs together with a transient puromycin expression vector. Puromycin was added to the cells from day 2 to day 5 for a short period of selection, and drug-resistant clones were picked up and amplified for genomic DNA PCR analyses ([Figure 1](#fig1){ref-type="fig"}B). The predicted cleavage site of each complementary target region is between positions −3 and −4 relative to the PAM sequence, and for the two gRNAs designed for *SMAD3* the interspace between these two cleavage sites is 44 bp long. We obtained 11 puromycin-resistant colonies, and genomic PCR analyses using primer sets flanking the two cleavage sites verified that seven colonies (7/11, 63.6%) showed biallelic genomic DNA deletion, while four (4/11, 36.4%) remained intact ([Figure 1](#fig1){ref-type="fig"}B). Western blotting confirmed that all seven colonies with genomic DNA deletion lacked SMAD3 expression, while all four uncut colonies expressed similar levels of endogenous SMAD3 ([Figure 1](#fig1){ref-type="fig"}B). We then performed Sanger sequencing for all seven cut PCR fragments, the results of which showed that in six colonies the cleavage sites were exactly between −3 and −4 bases upstream of both PAMs and that the cleaved blunt-ended genome DNAs were precisely ligated without indels ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}A). One exception was colony \#8, which showed one allele with indels after NHEJ ([Figure S1](#mmc1){ref-type="supplementary-material"}A).

We spent 3 days on *SMAD3* gRNAs cloning, 10 days on colony formation after electroporation, and 5 days on cell expansion before genotyping analysis. Therefore, we obtained *SMAD3* KO hESC lines within 20 days, which was much less laborious than our previous gene knockout strategy based on HDR ([@bib9]). Moreover, two additional aspects make this paired-KO strategy even more fascinating. First, the biallelic gene-targeting efficiency was extremely high and there was no monoallelic gene deletion verified in this case. Second, different from results obtained from other mammalian cells, which frequently incorporated indels during the DNA repair process ([@bib20]), paired-KO hESCs showed predicted target-site cleavage and precise end joining without indels. We also designed another primer pair to extend the genomic DNA PCR fragment, whose results showed that the amplified 1,385-bp DNA products equally remained in all clones, suggesting that no large DNA fragments were deleted ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Therefore, paired-KO is more predictable and controllable than conventional strategies induced by single DSB-triggered NHEJ. Via careful gRNA selection in controlling the site and length of the DNA fragments designed for deletion, PTCs can be easily introduced, and the engineered mRNAs with PTCs targeted for degradation through the nonsense-mediated decay (NMD) pathway ([@bib1], [@bib15], [@bib40]). Indeed, qPCR analysis showed 50% downregulation of *SMAD3* mRNA in knockout cells compared with the wild-type counterpart ([Figure 1](#fig1){ref-type="fig"}D). Therefore, the current paired-KO strategy is more predictable and does not culminate in non-natural proteins, which may exhibit unexplainable biological functions.

To test whether the paired-KO strategy could be applied to other PSC lines, we performed the same experiment in H1 hESCs and hiPSCs ([@bib30]). Again, the biallelic targeting efficiencies were 69.23% (9/13) and 66.67% (8/12) in H1 hESCs and hiPSCs, respectively ([Figures 1](#fig1){ref-type="fig"}E and 1F). Sanger sequencing data also confirmed that blunt ends were ligated without indels in both cell lines ([Figure S1](#mmc1){ref-type="supplementary-material"}D).

Off-target effects are major concerns for applying CENs in genetic engineering. Introducing two gRNAs in the cells could possibly increase the off-target effects. We therefore analyzed the integrity of the potential off-target sites predicted by the online program designed by Zhang\'s laboratory (<http://crispr.mit.edu/>) through Sanger sequencing. As shown in [Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F, five principal suspected off-target sites for each gRNA remained intact in a randomly picked biallelically targeted colony. These data suggest that the off-target effect is not a major issue for paired-KO.

We next repeated this paired-KO paradigm by targeting *CTNNB1* in hPSCs ([Figure 2](#fig2){ref-type="fig"}A). After electroporation and puromycin selection, 16 colonies were retrieved. Genomic DNA PCR results confirmed that six colonies were biallelically targeted, compared with only one monoallelic targeting colony and one mistargeted colony ([Figure 2](#fig2){ref-type="fig"}B). Western blotting and immunostaining experiments showed complete lack of CTNNB1 protein expression in the biallelically targeted lines ([Figures 2](#fig2){ref-type="fig"}C and 2D). Sanger sequencing and large DNA-fragment PCR amplification further revealed precise ligation of the double-cleaved blunt ends ([Figures 2](#fig2){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}A--2D). Moreover, *CTNNB1* mRNA level in biallelically targeted lines decreased up to 75%, further indicating an NMD response ([Figure 2](#fig2){ref-type="fig"}F). In addition, biallelic targeting of *CTNNB1* in H1 hESCs and hiPSCs was also achieved with high efficiency ([Figures 2](#fig2){ref-type="fig"}G and 2H). Again, we did not find any off-target mutations in the predicted off-target sites ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F).

We also designed another ten pairs of gRNAs targeting cell-cycle regulators, glucose transporters, or transcription factors related to lineage development ([Table 1](#tbl1){ref-type="table"} and [Figure S3](#mmc1){ref-type="supplementary-material"}). With just one single attempt, we successfully obtained all desired knockout hESC lines. Among the total colonies counted, the percentage of lines showing at least one-allele gene targeting ranged from 33.33% to 95.35%, while the biallelic targeting efficiency ranged from 18.75% to 75.00% ([Table 1](#tbl1){ref-type="table"}). For each gene knockout, we sequenced two to three genomic DNA PCR-amplified fragments, and found that they were all precisely repaired ([Figure S3](#mmc1){ref-type="supplementary-material"}). We screened all genes targeted for potential SNPs and found that *MAF*, *GLUT3*, and *SHISA3* had both SNPs within a range of 5 kb upstream or 5 kb downstream of the cleavage sites in H9 hESCs. We then sequenced all *MAF*, *GLUT3*, and *SHISA3* knockout colonies, the results of which showed that all colonies retained both upstream and downstream SNPs, indicating that no large genome fragments were deleted during the paired gRNA-mediated gene targeting.

One-Step Targeting of Multiple Genes with the Paired-KO Strategy {#sec2.2}
----------------------------------------------------------------

Given its high efficiency for biallelic gene targeting, we investigated whether the paired-KO strategy could be used for targeting of multiple genes simultaneously. *NF1* and *TP53* are two tumor-suppressor genes whose loss of function is closely related to many malignant tumors. We designed paired gRNAs targeting exon2 of *NF1* and exon1 of *TP53*, respectively, which were all closely downstream of the ATG start codon ([Figure 3](#fig3){ref-type="fig"}A). All four gRNAs were electroporated into H9 hESCs with Cas9. After puromycin selection, we retrieved a total of 22 colonies. Genomic PCR results showed that for *NF1*, 13 out of 22 colonies showed biallelic DNA deletion, while 18 of 22 colonies had biallelic deletions for *TP53* ([Figure 3](#fig3){ref-type="fig"}B). Among the 13 correctly targeted colonies for *NF1*, 11 were also biallelically targeted at the *TP53* loci, demonstrating a 50% double-knockout efficiency ([Figures 3](#fig3){ref-type="fig"}B and 3F). TP53, but not NF1, is expressed in hESCs and, indeed, the biallelically targeted \#4, \#16, and \#19 colonies showed no endogenous TP53 expression ([Figure 3](#fig3){ref-type="fig"}C). Sequencing results confirmed that the cleavage sites were just as expected, and the end-joining sites did not have any indels ([Figure 3](#fig3){ref-type="fig"}D). We then differentiated wild-type or double-knockout lines toward a neural fate for 25 days with a well-established protocol ([@bib9], [@bib52]), and qPCR analyses revealed a significant decay of both *NF1* and *TP53* mRNAs ([Figure 3](#fig3){ref-type="fig"}E).

Non-coding RNA Knockout via Paired-KO {#sec2.3}
-------------------------------------

Non-coding RNAs, including miRNAs and lncRNAs, play important roles in hPSC maintenance and lineage differentiation ([@bib31], [@bib33], [@bib44]). Since the open-reading-frame frameshift mediated by the traditional NHEJ strategy is not sufficient to ablate the expression of a non-coding RNA, antisense and RNAi are widely used methods for downregulating their expression, although with still controversial efficacy. For gene targeting we first chose MIR1193, located at chromosome 14, whose biological functions remain to be investigated. Two gRNAs flanking MIR1193 loci were designed and then electroporated into H9 hESCs with Cas9 ([Figure 4](#fig4){ref-type="fig"}A). Drug-resistant colonies were then validated by genomic PCR. Our results showed that 4 out of 12 colonies showed biallelic deletions, suggesting that miRNAs can be knocked out in hESCs through the paired-KO strategy as efficiently as protein-encoding genes ([Figure 4](#fig4){ref-type="fig"}B).

lncRNAs are defined as transcripts longer than 200 nucleotides without protein-coding potentials. The fragments we deleted for gene knockout described above via the paired-KO strategy were within 500 bp, so it remained unclear whether there is any tolerance for genomic DNA deletion related to the distance in between the double DSBs in hPSCs. *MALAT1* is an lncRNA proposed to play a role in tumor metastasis, which is coded by just one exon longer than 8,000 bp ([@bib21]). We designed five gRNAs whose target sites relative to the transcriptional start site (TSS) were about 0 bp (gRNA1), +500 bp (gRNA2), +1,000 bp (gRNA3), +3,000 bp (gRNA4), and +8,000 bp (gRNA5), respectively ([Figure 5](#fig5){ref-type="fig"}A). We then paired gRNA1 with each of the others and electroporated them in H9 hESCs to delete fragments of different length. gRNA1/2, gRNA1/3, and gRNA1/4 successfully yielded biallelic deletions with high efficiency, suggesting that the paired-KO strategy could be used to delete up to 3,000 bp of DNA fragments in the genome of hPSCs ([Figures 5](#fig5){ref-type="fig"}B--5D). However, in the gRNA1/5 pair designed to delete the entire lncRNA, only monoallelic targeting colonies were identified and no homozygous knockout colonies were successfully generated ([Figure 5](#fig5){ref-type="fig"}E).

Sanger sequencing further validated that in all four gRNA pairs, the double blunt ends were largely ligated with no indels, regardless of the length of deleted DNA fragments ([Figure 5](#fig5){ref-type="fig"}F). However, these results indicate an inverse relationship between the deletion size and deletion efficiency ([Figure 5](#fig5){ref-type="fig"}G). To fully eliminate *MALAT1* expression, we constructed another gRNA (gRNA0), which targeted a locus 1,000 bp upstream of the TSS; this 1,000-bp-long DNA fragment belongs to the core promoter region of *MALAT1* ([Figure 5](#fig5){ref-type="fig"}A). The gRNA0/1 pair was then electroporated into hESCs, and genomic PCR showed that among the six colonies chosen, three were biallelically targeted and one was monoallelically targeted ([Figure 5](#fig5){ref-type="fig"}H). qPCR analyses were then used to verify the mRNA expression levels of *MALAT1* among all these six colonies. The colonies with biallelic 1,000-bp promoter deletion almost completely lacked mRNA expression, while the monoallelically targeted colony remained at half of the lncRNA gene expression ([Figure 5](#fig5){ref-type="fig"}I). These data suggest that promoter-based gene targeting may serve as an alternative method for efficient lesion of genes, especially large lncRNAs.

Discussion {#sec3}
==========

Double gRNAs have been used to increase the gene-targeting efficiencies in either gene ablation or exogenous donor-based HDR ([@bib8], [@bib29], [@bib35], [@bib43], [@bib54]). It has also been reported that two adjacent DSBs could be used to create a deletion of the intervening fragment in both cultured cell lines and model organisms ([@bib3], [@bib38], [@bib47], [@bib53]). In some reports, the two DSBs were repaired through NHEJ and indels were sometimes introduced ([@bib3], [@bib5], [@bib7], [@bib24], [@bib39], [@bib55]). In our current study, the paired-KO triggered DSBs are mostly ligated through direct end joining without indels in hPSCs. When [@bib2] pioneered an experiment for replacing human *THY1* gene with its mouse homolog through double gRNAs/Cas9-mediated cleavage in hiPSCs, they also found DNA-fragment deletion in between the two cleaved sites and rejoining of the blunt ends without indels. This precise NHEJ or precise gene deletion after paired gRNA-mediated DSBs has also been observed in HEK293 cells and hematopoietic stem cells ([@bib17], [@bib24], [@bib43], [@bib54]). Given these predictable virtues of DNA cleavage and repair paradigms mediated by double gRNAs, the current paired-KO strategy is suitable for gene knockout in hPSCs without generating any non-natural proteins. Moreover, this paired gRNA strategy could also be used to delete a specific genomic fragment in hPSCs with designated *cis*-regulatory DNA element deletion, protein domain deletion, protein truncation, or mutation.

Another application of the paired-KO strategy is to ablate lncRNA expression in hPSCs. While \>100-kb fragments have been successfully deleted in cell lines and animals ([@bib3], [@bib7], [@bib50], [@bib53]), we find that DNA fragments larger than 8 kb exhibit extremely low efficiency for gene targeting in hPSCs. Therefore, we offered two alternative ways for ablating the expression of lncRNA. For deletion of a short lncRNA or a small fragment within a large piece, direct DNA deletion through paired-KO works as efficiently as with coding genes, while for a large lncRNA itself, removal of the core promoter region may be more practical for complete loss-of-function analysis.

In summary, we report that the paired-KO strategy is an efficient, outcome-predictable, and multiplexable genome-editing methodology, suitable for loss-of-function studies of both coding and non-coding genes in hESCs and hiPSCs.

Experimental Procedures {#sec4}
=======================

hPSC Culture {#sec4.1}
------------

hESCs (H9, WA09 or H1, WA01, passages 25--45, WiCell Agreement No. 14-W0377) were maintained on mouse embryonic fibroblast (MEF) feeder in a hESC culture medium as we previously described ([@bib9], [@bib52]). The components of the hESC culture medium (hESCM) are: DMEM/F12, 20% Knockout serum replacer, 1× minimal essential medium (MEM) non-essential amino acids solution, 1× L-glutamine solution, 0.1 mM β-mercaptoethanol, and 4 ng/mL fibroblast growth factor 2. Cells were passaged every 5 days through dispase (Gibco, 17105) digestion and the medium was changed every day. The hiPSCs line used in this study has been reported in our previous paper ([@bib30]).

Neural Differentiation of hPSCs {#sec4.2}
-------------------------------

The detailed procedure for neural differentiation of hPSCs was described previously ([@bib51], [@bib52]). In brief, after dispase digestion, hPSCs were removed from the MEF layers and then pipetted up and down against the bottom of a 50-mL conical centrifuge tube to break up the hPSC clusters into 100- to 200-μM pieces. Within the first 4 days, hESCs were suspended in hESCM to form embryoid bodies and medium was then switched to the neural induction medium to induce the cells toward a neuroectoderm fate. At day 6 post differentiation, cell aggregates were plated down on a laminin-coated culture surface. At day 17, neural progenitor cells were detached from the plate and maintained in suspension to form neurospheres. The recipe for NIM is as follows: DMEM/F12, 1× N2 supplement, 1× MEM non-essential amino acids solution, and 2 μg/mL heparin.

Construction of the gRNA Plasmids {#sec4.3}
---------------------------------

The blank gRNA vector with two BbsI restriction sites was as described previously ([@bib8]). The gRNA vector was digested with BbsI, gel purified, and ligated to the annealed oligos containing targeting sequences of designed gRNAs. For the detailed gRNA sequences for each gene, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Generation of Knockout hPSC Lines {#sec4.4}
---------------------------------

hPSCs were cultured in hESCM with 1 mM Y-27632 (Calbiochem, Y27632), a Rho kinase inhibitor, for 3 hr prior to electroporation. Cells were then digested by trypsin for 3 min into single cells and rinsed with PBS twice. Cells (1 × 10^7^) were electroporated with appropriate combination of Cas9 plasmids (5 μg) (Addgene \#44719), two gRNAs (5 μg), and CAG promoter-driven puromycin plasmid (5 μg) ([@bib12]) in 200 μL of electroporation buffer using the Gene Pulser Xcell System (Bio-Rad) at 250 V and 500 μF in 0.4-cm cuvettes (Phenix Research Products). Cells were treated with puromycin (0.5 μg/mL) from day 2 to day 5 post electroporation. After puromycin selection MEF-conditioned hESCM was supplied, and drug-resistant colonies could be picked up for genotyping analyses after 10 days post electroporation. Primer sets for genomic DNA PCR are provided in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Immunofluorescence {#sec4.5}
------------------

Coverslip cultures were fixed in 4% paraformaldehyde at room temperature for 10 min, washed two times with PBS, and incubated for 1 hr in blocking buffer (PBS, 10% donkey serum, 0.1% Triton X-100). Cells were incubated with primary antibodies at 4°C overnight followed by three washes and stained with the fluorescently conjugated secondary antibodies (1:1,000; Jackson Laboratories) for 1 hr. Nuclei were counterstained with Hoechst 33,258 (Sigma D9542) for 5 min. Primary antibodies used in this study include the following: CTNNB1 (1:1,000; mouse immunoglobulin G \[IgG\], BD Biosciences 610154), and Nanog (1:2,000; goat IgG, R&D Systems AF1997).

Western Blotting {#sec4.6}
----------------

Cells were lysed in RIPA^+^ buffer and protein concentrations were analyzed by the BCA kit (Thermo Scientific). Fifteen micrograms of total proteins was resolved on 10% SDS-PAGE gel, transferred to nitrocellulose membranes, and blotted for SMAD2/3 (1:1,000; rabbit IgG, Cell Signaling Technology \#8685), CTNNB1 (1:1,000; mouse IgG, BD Biosciences 610154), GAPDH (1:2,000; rabbit IgG, Santa Cruz Biotechnology SC25778), TP53 (1:1,000; rabbit IgG, Santa Cruz SC6243). The secondary antibodies were purchased from Jackson ImmunoResearch.

Statistical Analyses {#sec4.7}
--------------------

Data were analyzed using Student\'s t test for comparison of independent means with pooled estimates of common variances.
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![Efficient *SMAD3* Knockout in hPSCs through Paired-KO\
(A) Schematic representation of the paired-KO strategy for *SMAD3* knockout. The cleavage sites are pointed out by the scissors and arrows. The PAM sequences are in purple. The positions of the designed primers for genomic PCR are shown as arrows. PTC, premature translation termination codon.\
(B) Eleven colonies retrieved from *SMAD3* paired-KO in H9 hESCs. The top panel shows the genomic DNA PCR results and the lower panel shows western blotting results immunoblotted with the anti-SMAD2/3 antibody. Biallelically targeted colonies are labeled in red.\
(C) Genomic DNA sequences before and after the paired gRNA-mediated cleavage and repair. A representative Sanger sequencing peak map verifies precise rejoining of the double blunt ends.\
(D) qPCR data show decreased *SMAD3* mRNA expression in the biallelically targeted colonies. Data are presented as mean ± SEM of three independent experiments. ^∗∗∗^p \< 0.001, unpaired two-tailed Student\'s t test.\
(E and F) Efficient *SMAD3* targeting in H1 hESCs (E) and hiPSCs (F) through paired-KO. Biallelically targeted colonies are labeled in red.\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Efficient *CTNNB1* Knockout in hPSCs through Paired-KO\
(A) Schematic representation of the paired-KO strategy for *CTNNB1* knockout.\
(B) Genomic DNA PCR results of 16 colonies retrieved from *CTNNB1* paired-KO in H9 hESCs. Biallelically targeted colonies are labeled in red.\
(C) Western blotting experiments confirm complete lack of CTNNB1 protein expression in biallelically targeted colonies.\
(D) Confocal images show CTNNB1 and Nanog expression in wild-type (WT) and *CTNNB1* knockout (KO) H9 hESCs by immunostaining. Scale bar, 50 μm.\
(E) Genomic DNA sequences before and after the paired gRNA-mediated cleavage and repair. A representative Sanger sequencing peak map verifies precise rejoining of the double blunt ends.\
(F) qPCR data show decreased *CTNNB1* mRNA expression in the biallelically targeted colonies. Data are presented as mean ± SEM of three independent experiments. ^∗∗^p \< 0.01, unpaired two-tailed Student\'s t test.\
(G and H) Efficient *CTNNB1* targeting in H1 hESCs (G) and hiPSCs (H) through paired-KO. Biallelically targeted colonies are labeled in red.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![One-Step *NF1* and *TP53* Knockout in hESCs through Paired-KO\
(A) Schematic representation of the paired-KO strategy for double knockout of *NF1* and *TP53* through one-step manipulation in hESCs.\
(B) Genomic DNA PCR results of 22 colonies retrieved from H9 hESCs subjected to one-step targeting for both *NF1* and *TP53*. Lines with both *NF1* and *TP53* biallelically targeted are labeled in red.\
(C) Western blot shows complete TP53 knockout in the biallelically targeted lines.\
(D) Genomic DNA sequences before and after the paired gRNA-mediated cleavage and repair in *NF1* and *TP53* loci. Sanger sequencing data of a double-knockout line confirm the precise ligations of the double blunt ends for both *NF1* and *TP53*.\
(E) qPCR data show decreased NF1 and TP53 mRNA expression in day-25 neural differentiation derivatives from the double-knockout lines. Data are presented as mean ± SEM of three independent experiments. ^∗∗^p \< 0.01, unpaired two-tailed Student\'s t test.\
(F) Genome-targeting efficiency of *NF1* and *TP53*.](gr3){#fig3}

![Targeting miRNA in hESCs through Paired-KO\
(A) Schematic representation of the paired-KO strategy for MIR1193 knockout in hESCs.\
(B) Genomic DNA PCR results show the monoallelic or biallelic deletion of MIR1193 in hESCs. Biallelically targeted colonies are labeled in red.](gr4){#fig4}

![Targeting lncRNA in hESCs through Paired-KO\
(A) Schematic representation of the paired-KO strategy for *MALAT1* knockout in hESCs. Six gRNAs targeting different loci are designed and gRNA1 is paired with the remaining five gRNAs for deletion of desired fragments with different sizes. Forward and reverse primers are indicated by arrows.\
(B) Genomic DNA PCR results show the monoallelic or biallelic deletion of the proximal 500-bp exon fragment of *MALAT1* through gRNA1/2 combination. Biallelically targeted colonies are labeled in red.\
(C) Genomic DNA PCR results show the monoallelic or biallelic deletion of the proximal 1,000-bp exon fragment of *MALAT1* through gRNA1/3 combination. Biallelically targeted colonies are labeled in red.\
(D) Genomic DNA PCR results show the monoallelic or biallelic deletion of the proximal 3,000-bp exon fragment of *MALAT1* through gRNA1/4 combination. Biallelically targeted colonies are labeled in red.\
(E) Genomic DNA PCR results show the paired gRNA/Cas9 yield monoallelic deletion of the entire ∼8,000-bp exon fragment of *MALAT1* through gRNA1/5 combination.\
(F) Sanger sequencing data show precise ligation in all four types of gRNA pairs with different deletion sizes.\
(G) An inverse relationship between targeting efficiency and deletion size.\
(H) Genomic DNA PCR results show the monoallelic or biallelic deletion of the 1,000-bp promoter region of *MALAT1* through gRNA0/1 combination. Biallelically targeted colonies are labeled in red.\
(I) qPCR results show the mRNA expression levels of *MALAT1* in wild-type, heterozygous, or homozygous knockout colonies. Data are presented as mean ± SEM of three independent experiments. ^∗∗∗^p \< 0.001, unpaired two-tailed Student\'s t test.](gr5){#fig5}

###### 

Targeting Efficiencies of 14 Protein-Encoding Genes of Interest through Paired-KO in H9 hESCs

Table 1

  Gene        Clone Number   Targeted Number   Biallelically Targeted Number   Targeting Efficiency (%)   Biallelically Targeted Efficiency (%)
  ----------- -------------- ----------------- ------------------------------- -------------------------- ---------------------------------------
  *ADM*       19             12                8                               63.16                      42.11
  *BHLHE40*   17             11                7                               64.71                      41.18
  *DDIT4*     26             24                13                              92.31                      50.00
  *GLUT3*     16             8                 3                               50.00                      18.75
  *SHISA3*    19             17                10                              89.47                      52.63
  *CTNNB1*    16             7                 6                               43.50                      37.50
  *SMAD3*     31             19                13                              61.29                      41.94
  *MAF*       18             9                 8                               50.00                      44.44
  *SP8*       15             5                 5                               33.33                      33.33
  *MEIS2*     5              2                 2                               40.00                      40.00
  *TP53*      23             20                18                              86.96                      78.26
  *NF1*       23             18                13                              78.26                      56.52
  *ASCL1*     43             41                31                              95.35                      72.09
  *FOXG1*     8              6                 6                               75.00                      75.00

See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

[^1]: Co-first author
